Monday saw the break of an 8-week handle on modest volume. The move was supported by a resistance break in the MACD trigger line although on-balance-volume remained unchanged. There was no news to account for the breakout and there was no net change in the point-n-figure chart (which shows an extended decline from the glory days of $56 a share). GTC buy orders to $4.45 may be sufficient for a price fill but a move over $5 will set the momentum players alight, and a move to $6 will see a breakout on the point-n-figure chart. One to watch.
Profile:
Cerus Corporation develops products for cancer, infectious disease, and blood safety. It develops cancer immunotherapies based on its Listeria vaccine platform combined with disease antigens. The company is also developing the INTERCEPT Blood System, which is based on the company's Helinx technology for controlling biological replication. The INTERCEPT Blood System is designed to enhance the safety of donated blood components by inactivating viruses, bacteria, other pathogens, and white blood cells. This system targets and inactivates blood-borne pathogens, such as HIV and hepatitis B and C, as well as harmful white blood cells, while leaving the therapeutic properties of the blood components intact. Cerus is also developing a proprietary vaccine platform to stimulate the immune system to target and attack cancer cells and infectious diseases. The company has collaboration agreements with Baxter Healthcare Corporation and BioOne Corporation for the joint development of the INTERCEPT Blood System for platelets and plasma; and with MedImmune, Inc. to co-develop a therapeutic vaccine designed to treat cancers of the breast, prostate, and colon, as well as metastatic melanomas. Cerus was incorporated in 1991 and is based in Concord, California
Cerus Corp.- Relative Strength... it left a long white candlestick on the chart with above average volume ;)
Do you have a target price? Thanks.
Profile Get Profile for:
Cerus Corp.
2411 Stanwell Drive
Concord, CA 94520
Phone: 925-288-6000
Fax: 925-603-9099
Web Site: http://www.cerus.com
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 83
BUSINESS SUMMARY
Cerus Corporation develops products for cancer, infectious disease, and blood safety. It develops cancer immunotherapies based on its Listeria vaccine platform combined with disease antigens. The company is also developing the INTERCEPT Blood System, which is based on the company's Helinx technology for controlling biological replication. The INTERCEPT Blood System is designed to enhance the safety of donated blood components by inactivating viruses, bacteria, other pathogens, and white blood cells. This system targets and inactivates blood-borne pathogens, such as HIV and hepatitis B and C, as well as harmful white blood cells, while leaving the therapeutic properties of the blood components intact. Cerus is also developing a proprietary vaccine platform to stimulate the immune system to target and attack cancer cells and infectious diseases. The company has collaboration agreements with Baxter Healthcare Corporation and BioOne Corporation for the joint development of the INTERCEPT Blood System for platelets and plasma; and with MedImmune, Inc. to co-develop a therapeutic vaccine designed to treat cancers of the breast, prostate, and colon, as well as metastatic melanomas. Cerus was incorporated in 1991 and is based in Concord, California.
Right here Setravis CERS already started... i hope we make money from here :D
New Recent 52 week high.
Another biotech that I like,experiencing good growth but is not profitable.
Therefore, its speculative in nature
Small-Cap growth company in the health care sector. Develops technologies to provide safer and more effective options to patients in areas with unmet medical needs, particularly within the fields of cancer, infectious disease and blood safety
Price-to-cash-flow ratio well below industry average.
BRIEF: For the nine months ended 30 September 2005, Cerus Corporation's revenues rose 71% to $18.8M. Net income totaled $17M vs. a loss of $25.8M. Revenues reflect increased development funding, government grants & cooperative agreement and the presence of product sales revenues. Net income also reflects decreased R&D expenses, absence of
restructuring expenses and presence of gain on loan settlement. http://www.ceruscorp.com
Cup with Handle (Continuation) Pattern
Breakout....
I'm sorry Terlisa,
I didn't see your thread on this stock. Excuse me.
I will get Ramsburgh to merge mine into yours.
You came up with a nice pick.......Applaud you work.... ;)
But, Please do excuse me.
Quote from: setravis on December 12, 2005, 12:43:50 AM
I'm sorry Terlisa,
I didn't see your thread on this stock. Excuse me.
I will get Ramsburgh to merge mine into yours.
You came up with a nice pick.......Applaud you work.... ;)
But, Please do excuse me.
Setravis, can you get Ramsburg to bring my Birthday Cake too :D ;D :D ;D..... i'm 27 now and i want to learn more in stock market ;)...........3SOF MORE POWER!!!!!!!
Quote from: Terlisa on December 12, 2005, 12:53:41 AM
Setravis, can you get Ramsburg to bring my Birthday Cake too :D ;D :D ;D..... i'm 27 now and i want to learn more in stock market ;)...........3SOF MORE POWER!!!!!!!
Quote
There we go Terlisa , I got it merged! ;D
Happy Birthday to you and may you have many more to come.I wish you wealth, health and happiness. ;) From the post I read of yours,I think you are doing very well. ;D Good trading to you.
Such a young knowledgeable trader. ;)
Quote from: Terlisa on December 12, 2005, 12:53:41 AM
Setravis, can you get Ramsburg to bring my Birthday Cake too :D ;D :D ;D..... i'm 27 now and i want to learn more in stock market ;)...........3SOF MORE POWER!!!!!!!
Happy Birthday Terlisa !
Here's your special Birthday Cake, specially made here at 3SOF for you ;D:
Quote from: Ramsburg on December 12, 2005, 01:31:50 AM
Happy Birthday Terlisa !
Here's your special Birthday Cake, specially made here at 3SOF for you ;D:
Quote
Wow!!!... you delivered my cake fast Ramsburg :D :D Thanks (applaud for that) also to u Setravis ;)
Anyway, because it's my birthday today i'll applaud everybody on this thread ;D ;D ;D ;D
Quote from: Terlisa on December 12, 2005, 12:36:38 AM
Right here Setravis CERS already started... i hope we make money from here :D
Happy b-day to you,Terlisa!
Wow, very nice b-cake Ramsburg :o :P
Great pick, CERS is good long term play! Broke its 52 week high with decent volume, looks bullish! However, I would say that it might get some slight profit taking days next week, if not with lighter volume, unless there is some signifcant news which will again send CERS higher! So at this point, it is a bit extended but the momentum could be continue if the volume still there, good luck to all who is in this gem! 8)
Cerus Corporation engages in the research, development, clinical testing, and commercialization of blood safety systems, immunotherapies for cancer and infectious disease. It develops cancer immunotherapies based on its Listeria vaccine platform combined with disease antigens. The company also offers the INTERCEPT Blood System, which is based on the company's Helinx technology for controlling biological replication.
CERS bounced off an ascending trendline last week and has moved up on a slight increase in volume. Yesterday's action was based on this news:
Cerus Corporation Receives Milestone Payment From BioOne (http://biz.yahoo.com/bw/061226/20061226005117.html?.v=1)
There is a lot of overhead resistance between 6.50 and 7.25 but technicals are improving with these nice rounded bottoms on RSI and Slow STO as well as an improving MACD and the confirmed support at the ascending TL.
"CERS" Threads have been Merged.
Please use the search before starting new threads on a Stock Pick.
Chances are a thread already exist.
So why not post whatever you have to comment about on that pick to that thread.
"Simplicity" My fellow traders. ;)
All history on a stock pick in 1 thread is awesome. ;)
Just trying to get threads together,so we don't have a numerous amount floating around on the same stock.
Thank You....and good luck with all your trades....make some $$$ ;D
Happy New Year ! May it be Prosperous for all @ 3SOF...... ;)
I'm not sure where the new thread was started since there was already a post above mine from June, 2005. Thanks for merging them though! ;D
Volume picked up again yesterday with some really nice buying volume in the afternoon before selling ensued. Indicators continue to improve but watch for how CERS reacts first to the 20ma and then the 200ma (if it gets there).
Nice move yesterday on the anticipation of this news item announced after the closing:
Cerus Announces French Regulatory Approval of the INTERCEPT Blood System for Plasma (http://biz.yahoo.com/bw/070117/20070117005386.html?.v=1)
Up over 5% pre-market.